Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_assertion description "[(a) ER?(+) breast cancer cells dysfunctional for TP53 which proliferate irrespective of low estrogen and chemical MEK inhibition are likely to increase metabolic consumption becoming increasingly susceptible to 3-BrPA; (b) targeting the pyruvate pathway may improve response to endocrine therapy in ER?(+) breast cancer with p53 dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_assertion evidence source_evidence_literature NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_assertion SIO_000772 24486524 NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_assertion wasDerivedFrom befree-20150227 NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_assertion wasGeneratedBy ECO_0000203 NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP646422.RA97rqB7JW0s8FLJixAxevWMAOLo1lVN1SG53yZ8cmoWQ130_provenance.